Differences in the prevalence of Chlamydia trachomatis reported by two laboratories using the direct immunofluorescence test

JAMA ◽  
1987 ◽  
Vol 257 (19) ◽  
pp. 2593c-2593
Author(s):  
B. D. Reed
2002 ◽  
Vol 51 (1) ◽  
pp. 95-100
Author(s):  
К. V. Shalepo ◽  
E. V. Shinitsyna ◽  
A. N. Savitsheva ◽  
M. Domeika

The results of Chlamydia trachomatis detection in different urogenital samples (vagina, cervix, urethra, urine) are presented in this report. The study was carried out for the period of 1999 to 2000. A total of 397 women and 253 men were examined. Cervical, urethral and vaginal swabs from women, and urethral, first voided urine (FVU) specimens from men were tested. For diagnosis of Chlamydia, trachomatis the following methods were used: polymerase chain reaction (PCR), direct immunofluorescence test (DIF) and cell culture (CC). In male samples, more often chlamydiae were detected in the urethra (11,6%), more rarely - in the FVU (6%). When female samples were tested, more often C. trachomatis was found in the vagina (18,4%), and less often - in the cervix (14. 4) and the urethra (8. 8%). The sensitivity and specificity of the methods used to test urogenital samples were determined. The PCR sensitivity and specificity was shown to be 75 and 100% for C. trachomatis detection in the cervix, 75 and 97. 5% - in the female urethra, and 63 and 99% - in the vagina, respectively. The PCR sensitivity and specificity was found to be 78 and 100% in the male urethral specimens and 100 and 99. 6% in the FVU, respectively. The sensitivity of cell culture method used for chlamydiae detection in cervical, female and male urethral samples was low - 33. 9, 47. 1 and 50% respectively. The CC specificity was 100%.


2009 ◽  
Vol 62 (1-2) ◽  
pp. 7-12 ◽  
Author(s):  
Vera Jerant-Patic ◽  
Vesna Milosevic ◽  
Gordana Kozarev

The authors present results of a planned prospective study of infections with Chlamydia trachomatis in women. Direct immunofluorescence test (DIF) for proving Chlamydia trachomatis antigens in endocervical smear (by means of monoclonal antibodies), ELISA test for proving IgG antibodies against Chlamydia trachomatis in sera and RVK method for proving antibodies against group Chlamydia-antigen were applied to test 288 women (aged 19-67), previously thoroughly anamnestically and clinically examined. Chlamydia trachomatis infection was found in 29.51% of the cases, equally distributed in all age groups. The authors analyzed frequency of Chlamydia positive findings according to clinical diagnoses, parity, relevant data from gynecological history, as well as results of vaginal secretion tests and Papanicolaou smear findings.


Author(s):  
Fahimeh Asadi-Amoli ◽  
Zohreh Nozarian ◽  
Vahid Mehrtash ◽  
Hooshang Beheshtnejad ◽  
Avishan Shabani

1992 ◽  
Vol 3 (6) ◽  
pp. 434-436 ◽  
Author(s):  
Ana Berta Cañas Posada ◽  
Jon Jonasson ◽  
Leonor de Linares ◽  
Solgun Bygdeman

The prevalence of urogenital infection caused by Chlamydia trachomatis was examined in 100 non-pregnant women with cervicitis, and 100 healthy women, in San Salvador City, El Salvador. Pharmacia Chlamydia EIA test was used for the detection of chlamydial antigen in urethral and cervical specimens from all the women. Direct immunofluorescence was used for confirmative tests on the EIA positive and the negative gray zone samples. C. trachomatis antigen was detected in 28% of the women with cervicitis compared with 5% in the group of healthy women ( P < 0.001). The cervicitis group were also screened for Neisseria gonorrhoeae which was isolated from 12% of them. One strain out of 12 was beta-lactamase producing (PPNG). Five per cent of the women with cervicitis had simultaneous C. trachomatis and N. gonorrhoeae infections.


Sign in / Sign up

Export Citation Format

Share Document